Corona Remedies Limited
ListedMainboardHealthcare & Pharmaceuticals · NSE / BSE
Corona Remedies Limited, incorporated in August 2004, is a pharmaceutical company engaged in the development, manufacturing, and marketing of products across key therapeutic areas including women’s healthcare, cardiology, pain management, urology, and multispecialty segments. As of December 2024, its portfolio includes 67 brands covering women’s health, cardio-diabetic care, pain relief, urology, and multispecialty products such as vitamins, minerals, nutrition, gastrointestinal, and respiratory medications. The company has established a strong pan-India presence with 2,598 medical representatives across 22 states, ensuring deep engagement with healthcare professionals and hospitals. It operates two manufacturing facilities in Gujarat, supporting its production and quality-focused growth strategy in the Indian Pharmaceutical Market.
Price Band
₹1008 – ₹1062
Issue Size
₹655 Cr
Lot Size
14 shares
GMP
₹344
+32.4%
Est. Listing
₹1406
at current GMP
Subscribed
144.49x
overall
Open
8 Dec 2025
Close
10 Dec 2025
Allotment
11 Dec 2025
Refund
12 Dec 2025
Demat Credit
13 Dec 2025
Listing
15 Dec 2025
Last updated 12 days ago
Key Highlights
- •Leading player in the Healthcare & Pharmaceuticals segment
- •Price band established at ₹1008 - ₹1062 per equity share
- •Minimum bid lot is 14 shares
- •Estimated listing target of ₹1406 based on current grey market activity